EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East
Wednesday, Virax Biolabs Group Limited (NASDAQ:VRAX) entered into a distribution agreement with a supplier of (RT) PCR Mpox virus detection kits to commercialize them in some European and Gulf countries.
週三，Virax Biolabs Group Limited (NASDAQ: VRAX)與供應商簽訂了分銷協議，用於在一些歐洲和海灣國家商業化(RT) PCR Mpox病毒檢測套件。
The RT PCR Mpox virus detection kits are approved for sale in Europe and also authorized by the Medicines and Healthcare Products Regulatory Agency, the product regulatory agency for the United Kingdom.
RT PCR Mpox病毒檢測套件已獲得歐洲銷售批准，並獲得英國藥品和醫療保健產品監管局（Medicines and Healthcare Products Regulatory Agency）的授權。該機構是英國的產品監管機構。
Earlier this month, the World Health Organization issued an international public health emergency due to higher cases of mpox infection in African countries.
本月早些時候，世界衛生組織因非洲國家mpox感染病例增加而宣佈國際公共衛生緊急狀態。
Also Read: EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes.
也可閱讀：獨家：Virax Biolabs推出免疫譜系解決方案，用於評估後病毒綜合症的適應性免疫。
These tests perform with a sensitivity of 96.7% and specificity of 93.72%, with the ability to deliver results in under 70 minutes.
這些測試具有96.7%的靈敏度和93.72%的特異性，並能在70分鐘內交付結果。
Under the terms of the agreement, Virax is authorized to import, sell, and distribute Virax-branded Mpox virus Nucleic Acid Detection Kits in European countries, including the United Kingdom, France, Portugal, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Spain, Switzerland, Austria, and the GCC set of nations, including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.
根據協議條款，Virax有權在歐洲國家（包括英國、法國、葡萄牙、荷蘭、比利時、瑞典、芬蘭、丹麥、挪威、德國、西班牙、瑞士、奧地利）以及海灣合作委員會（GCC）成員國（包括巴林、科威特、阿曼、卡塔爾、沙特阿拉伯、阿聯酋）進口、銷售和分銷Virax品牌Mpox病毒核酸檢測套件。
Cosmos Health Inc. (NASDAQ:COSM) announced under its agreement with Virax Biolabs it continues to hold the rights to distribute mpox virus real-time PCR detection kits, with exclusive distribution rights in Greece and Cyprus and non-exclusive distribution rights across Europe.
Cosmos Health Inc. (NASDAQ:COSM)宣佈在與Virax Biolabs的協議下，持續擁有分銷mpox病毒實時PCR檢測套件的權利，在希臘和塞浦路斯擁有獨家分銷權，並在整個歐洲擁有非獨家分銷權。
Price Action: At last check on Wednesday, VRAX stock was down 4.70% to $4.65 during the premarket session.
價格走勢：在週三最後一次檢查時，VRAX股票在盤前交易中下跌了4.70%，至4.65美元。
- Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder.
- 強生-合作伙伴addex therapeutics選擇研究化合物治療物質使用障礙。
譯文內容由第三人軟體翻譯。